Lexaria Bioscience (LEXX) Capital Expenditures Growth (1y) (2011 - 2026)
Lexaria Bioscience (LEXX) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.63 Mn |
2.11 Mn |
20,000.00 |
4,081,500.00% |
| Date | Value |
|---|
| Feb 28, 2026 |
4,081,500.00% |
| Aug 31, 2025 |
-100.00% |
| Nov 30, 2022 |
-51.62% |
| Jul 31, 2014 |
123,856.00% |
| Jan 31, 2014 |
-32.69% |
| Oct 31, 2013 |
0.71% |
| Jul 31, 2013 |
-99.95% |
| Jan 31, 2013 |
-17.83% |
| Oct 31, 2012 |
-96.25% |
| Jan 31, 2012 |
-81.31% |
| Oct 31, 2011 |
152.93% |
